November 19, 2020
FDA authorizes first home test for COVID-19
Editor's Note
The Food and Drug Administration (FDA) on November 17 issued an emergency use authorization for the first rapid COVID-19 self-test that a person can administer at home.
The Lucira COVID-19 All-In-One Test Kit has to be prescribed by a healthcare provider, and the healthcare provider has to report the results to public health authorities. The home test is for those 14 years of age or older.
The test also can be used in patient care settings, with nasal swab specimens collected by the provider in those under age 14.
Free Daily News
- Hospital’s anesthesia reforms slash carbon footprint, expenses
- Study: Shifting imaging to outpatient centers could save billions
- Report: Health system margins shrink as hospital revenue grows
- Study: Cataract surgery increases diabetic retinopathy progression
- FDA announces Class 1 endovascular system, anesthesia system recalls
- Cost-shifting concerns rise as GOP eyes Medicaid cuts
- Study: Prolonged general anesthesia linked to long-term cognitive decline
- Real-time cancer detection improves brain surgery precision
- Research highlights anesthesia provider knowledge gap on drug, hormonal contraceptive interactions
- Healthcare CFOs prioritize cost control, data-driven decisions
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement